Use of olaparib in patients with advanced gastric cancer

Lancet Oncol. 2018 Feb;19(2):e75. doi: 10.1016/S1470-2045(18)30023-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Double-Blind Method
  • Humans
  • Paclitaxel*
  • Phthalazines
  • Piperazines
  • Stomach Neoplasms*

Substances

  • Phthalazines
  • Piperazines
  • Paclitaxel
  • olaparib